Zentalis Pharmaceuticals ZNTL Ratios (2019-2026)

NASDAQ ZNTL
$2.75 +0.04 (+1.29%)
As of: Sep 30, 2026 · 12:27 PM EDT
Reported Financials

Zentalis Pharmaceuticals Quarterly Ratios

Periods 29 quarters
Latest Jun 2026

Zentalis Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
25.11%-177.47%
EBIT Margin
-61.06%-185.55%
EBITDA Margin
-60.26%-184.33%
Operating Margin
-61.06%-185.55%
Net Margin
24.82%-176.71%
FCF Margin
-128.24%-147.78%
Efficiency
Assets AverageAssets Avg.
359.52M444.79M430.09M486.77M548.52M534.25M514.33M555.39M603.58M568.70M554.58M524.58M471.17M440.50M407.18M367.86M339.48M308.11M271.02M234.20M
Equity AverageEquity Avg.
320.80M379.24M340.07M394.24M450.78M431.38M409.84M454.47M502.59M459.64M448.08M420.68M368.46M345.76M316.28M284.94M263.68M234.54M199.44M163.16M
Asset Utilization RatioAsset Util.
0.070.080.090.150.070.070.08
Valuation
Price to SalesP/S
27.597.176.463.204.263.114.06
Price to BookP/B
7.6410.496.663.392.882.752.653.812.942.452.440.760.740.640.390.300.430.430.912.42
Enterprise Value
2,971.79M3,764.77M2,073.04M1,546.02M1,192.35M1,151.06M986.31M1,725.31M1,306.43M589.29M1,081.53M253.85M220.51M-135.92M-205.90M-202.96M-169.20M-152.63M-45.25M172.98M
Market Capitalization
3,012.03M3,823.95M2,103.24M1,600.83M1,234.67M1,193.90M1,022.41M1,991.73M1,417.05M1,072.10M1,119.15M290.83M261.83M215.99M114.40M83.68M109.09M93.27M166.51M347.59M
Return Ratios
Return on Sales [ROS]ROS
-61.06%-543.77%-515.94%-185.55%-789.32%-681.04%-615.16%
Return on Capital Employed [ROCE]ROCE
-65.16%-54.02%-57.96%-53.04%-45.25%-47.59%-51.17%-54.57%-52.02%-59.98%-51.89%-48.17%-50.27%-49.31%-59.27%-55.64%-54.67%-56.27%-61.51%-78.02%
Return on Assets [ROA]ROA
-43.49%-37.34%-40.66%-38.67%-42.34%-44.38%-46.88%-51.37%-47.44%-51.40%-39.49%-37.12%-38.06%-37.65%-55.06%-44.25%-43.98%-44.48%-45.80%-59.58%
Return on Equity [ROE]ROE
-48.74%-43.80%-51.43%-47.74%-51.52%-54.97%-58.84%-62.78%-56.97%-63.59%-48.88%-46.29%-48.67%-47.97%-70.88%-57.13%-56.63%-58.44%-62.24%-85.52%

Zentalis Pharmaceuticals Ratios API

Pull Zentalis Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ZNTL&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY